logo-big

About Us

Synolo® Biometrics was created to commercialize the infant biometrics collection technology developed at UC San Diego with funding from the Gates Foundation. This technology was clinically proven in a large joint study performed in a major hospital in Mexico.

Since forming Synolo® in 2021, the original "Panda" prototype has been transformed into a fully commercialized unit with proprietary, real-time, high resolution image processing, ergonomic design, and a robust SDK for OEM integration that is already successfully deployed in the field in the US and Brazil.

2025

Contact Top Release

Synolo® Neo is the only biometrics device to offer both contact and non-contact capabilities in the same device. You can now rapidly switch between our patented non-contact and contact tops to capture infant, child and adult fingerprints with either technology in high resolution, age corrected images, providing a highly flexible solution for lifelong identification.

Contact Top Release

2025

FBI Certification

Synolo® Neo becomes the first non-contact device designed for infant and child as well as adult biometrics to receive FBI PIV single finger certification.

FBI Certification

2024

Synolo® Launches in Brazil

  • Synolo® announces expansion into Latin America with the commercial launch of the Synolo® Neo fingerprint reader in Brazil
  • This initiative reinforces the company's commitment to providing innovative biometric and civil identification solutions that ensure the protection of babies and children from the earliest stages of life through key local partners
Synolo® Launches in Brazil

2023

First Commercial POC

  • NEC, a major global company with 110,000 employees and operations in 50 countries, announced a POC study using Synolo® Neo
  • Short term study (1-2 months) conducted at a major hospital in South America
  • Collected fingerprints from ~500 infants at birth and verified on discharge
First Commercial POC

2022

Synolo® Neo Launched

  • Improved ergonomics and usability
  • Real-time image processing
  • Interchangeable aperture thumbwheels
  • Optimized imaging technology with proprietary age-correction algorithms
  • Simplified manufacturing and assembly
Synolo® Neo Launched

2022

CITeR/NSF Study Launched

  • POC study at NY hospitals, clinics and schools
  • ~300 infants/children covering birth to 15 years old
  • Multi-year study conducted by CITeR and Clarkson University
CITeR/NSF Study Launched

2021

Synolo® Biometrics Formed

Synolo® Biometrics was formed by key members of the UCSD team and seasoned entrepreneurs to commercialize the technology. Funding was provided by BioPacific Investors angel group.

Synolo® Biometrics Formed

2019

UCSD/Gates POC Study

The resulting pilot study led by UCSD's team validated that a new, non-contact, high resolution fingerprint device (the 'Panda') combined with novel image processing algorithms, could successfully identify 500 newborns and infants in a hospital setting.

UCSD/Gates POC Study

2017

Gates Foundation Grant

A $5M grant provided to UC San Diego started it all. The Gates Foundation approached Dr. Eliah Aronoff-Spencer to lead a project to determine if - and how - newborns and infants could be identified for vaccine delivery using biometrics.

Gates Foundation Grant

Synolo® Team

Rob Lewis

Rob Lewis

Chairman & Co-founder

Greg Scott

Greg Scott

CEO & Co-founder

Steve Saggese, PhD

Steve Saggese, PhD

CTO & Co-founder

Eliah Aronoff-Spencer, MD, PhD

Eliah Aronoff-Spencer, MD, PhD

Co-founder & Neo Visionary

Rafael Cury Lucchesi

Rafael Cury Lucchesi

Business Development Manager

Ready to innovate with infant biometrics?

Get in touch and discover how Synolo® Neo can transform civil identification.

Contact Us
LinkedIn© 2026 Synolo® Biometrics, Inc. All rights reserved.